Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/7/2026

Preconception Management of Anxiety in Bipolar II with Comorbid ADHD

Epidemiology & Pathophysiology

  • Approximately 10 % of adults with recurrent anxiety disorders have comorbid ADHD, highlighting the need to screen for ADHD when anxiety is present. 1
  • Effective treatment of ADHD is essential for achieving remission of co‑occurring depression and anxiety, underscoring ADHD as a driver of overall functional outcome. 1
  • Discontinuation of psychostimulant medication during pregnancy is associated with a significant rise in depressive symptoms despite continued antidepressant therapy, indicating that untreated ADHD worsens psychiatric comorbidities. 3

Pharmacologic Strategy

Continue ADHD Stimulant Through Conception & Pregnancy

  • Amphetamine‑based stimulants (e.g., Adderall XR) have no demonstrated association with major congenital malformations, including cardiac defects, based on moderate‑quality systematic reviews. 4 – moderate evidence
  • Maintaining a low daily dose (5 mg) is well below typical therapeutic ranges (10–50 mg), thereby minimizing any theoretical teratogenic risk. 3
  • Stopping ADHD medication can deteriorate maternal mental health and functional capacity, indirectly jeopardizing fetal development. 3 – clinical consensus
  • Untreated ADHD is linked to higher rates of spontaneous abortion and preterm birth. 3 – observational data

Optimize Mood Stabilization

  • Anxiety manifestations in bipolar disorder frequently reflect insufficient mood stabilization rather than a primary anxiety disorder, supporting dose optimization of mood stabilizers before adding separate anxiolytics. 1

Avoid Adding New Anxiolytics

  • Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants are not recommended as monotherapy in bipolar disorder because of the risk of inducing a manic switch. 8 – high‑level guideline
  • Introducing additional psychotropic agents during pregnancy raises polypharmacy risks without clear benefit. 6 – clinical caution

Non‑Pharmacologic Interventions

  • Dialectical Behavior Therapy (DBT) has been shown to reduce ADHD symptoms and comorbid anxiety/depression in adults with ADHD, with specific modules (distress tolerance, emotion regulation) targeting anxiety. 3 – moderate evidence
  • Cognitive Behavioral Therapy (CBT) is the most extensively studied psychotherapeutic approach for ADHD and possesses strong efficacy for anxiety disorders. 6 – high‑level evidence
  • Mindfulness‑based interventions improve parental self‑efficacy and multiple dimensions of mindfulness (e.g., acting with awareness, non‑judgment), supporting overall mental health during the preconception period. 3 – pilot data

Monitoring & Follow‑Up

  • Conduct weekly mood symptom assessments while adjusting medications to promptly identify emerging manic or depressive features. 6
  • Ensure adequate sleep and nutrition, which are critical for managing ADHD symptoms throughout pregnancy. 6
  • Maintain weekly psychotherapy (DBT or CBT) focused on anxiety and ADHD management to reinforce coping strategies. 3

Common Pitfalls to Avoid

  • Do not discontinue all psychiatric medications when pregnancy is planned; abrupt cessation commonly leads to relapse and worsened maternal‑fetal outcomes. 3
  • Do not treat anxiety in isolation without first addressing underlying bipolar disorder and ADHD, as this approach rarely achieves remission. 1
  • Do not add SSRIs for anxiety in bipolar patients because of the heightened risk of a manic switch. 8